|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||1.83 / 7.80|
Company Expects to Report Full Quarterly Financial Results and Host Conference Call on July 27, 2017
First Quarter Prescription Volumes Grew Year-Over-Year for Zohydro ER® with BeadTek™ and Silenor®
Fourth Quarter Prescription Volumes Grew Year-Over-Year for All Three Core Brands, Treximet®, Zohydro ER® with BeadTek™ and Silenor®
Regains Compliance with NASDAQ Listing Rule 5605(c)(2)(A)
Company to Begin Focused Product Promotion Activities in Early Q4 2016
Patents cover important safety information related to dosing patients
These under-$10 stocks look ready to break out and trade higher from current levels.
Here's a technical look at how to trade five stocks that look poised to break out and trade higher from current levels.
Reorganization Expected to Drive Long-Term Revenue Growth, Improve Profitability and Result in Annualized Cost Savings of Approximately $10 Million
These under -$10 stocks are poised to breakout and trade higher from current levels.
Trade-Ideas LLC identified Pernix Therapeutics Holdings (PTX) as a weak on high relative volume candidate